Abstract
Hypothyroidism is a common endocrine disorder characterized by insufficient thyroid hormone production and there are increasing reports of hypothyroidism being associated with a variety of complex diseases. However, whether these associations share a common genetic basis remains unclear. In this study, we investigated the shared genetic architecture underlying hypothyroidism and three immune-related diseases, including sarcoidosis, chronic sinusitis, and interstitial lung disease (ILD) endpoints, using large-scale genome-wide cross-traits analysis. Linkage disequilibrium score regression and genetic covariance analysis revealed significant genetic correlations between hypothyroidism and each of the three diseases. Cross-trait meta-analyses identified 26 shared risk loci between hypothyroidism and other three diseases. Cell-type SNP heritability enrichment analyses highlighted that central memory CD4⁺ T cells in the blood are co-enriched by these four diseases, which was further confirmed by co-localization analysis (posterior probability>0.9). Furthermore, DOCK6 and CD226 were identified as candidate causal genes shared by hypothyroidism and sarcoidosis, while RIPK2 was found as a hypothyroidism-driven plasma protein that may mediate the risk of ILD endpoints. Overall, these findings provide new insights into the shared genetic underpinnings of hypothyroidism and immune-related diseases and offer potential targets for comorbidity risk assessment and therapeutic intervention.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Changes were made to the textual and structural aspects of the manuscript.
Data Availability
All the datasets analyzed during the current study are publicly available.
